Recombinant ALDH1A1 antibody (AA 315-434)
Quick Overview for Recombinant ALDH1A1 antibody (AA 315-434) (ABIN7873870)
Target
See all ALDH1A1 AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- AA 315-434
-
Purpose
- Recombinant ALDH1A1 Antibody / Aldehyde Dehydrogenase 1A1 (azide and preservative free)
-
Purification
- Protein A/G affinity
-
Immunogen
- A portion of amino acids 315-434 was used as the immunogen for the recombinant ALDH1A1 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the recombinant ALDH1A1 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the recombinant ALDH1A1 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- ALDH1A1 (Aldehyde Dehydrogenase 1 Family, Member A1 (ALDH1A1))
-
Alternative Name
- ALDH1A1
-
Background
- ALDH1A1 belongs to the ALDH enzymes, a family of evolutionarily conserved enzymes comprised of 19 isoforms that are localized in the cytoplasm, mitochondria or nucleus. ALDH1A1 is predominantly expressed in the epithelium of testis, brain, eye, liver, kidney, as well as neural and hematopoietic stem cells. Reportedly, high ALDH1A1 expression is found in solitary fibrous tumor (SFT) and hemangiopericytoma (HPC), compared to meningiomas and synovial sarcomas. In combination with CD34, ALDH1A1 may be useful for the differentiation among SFT, HPC, meningioma, and synovial sarcoma.
-
UniProt
- P00352
-
Pathways
- Dopaminergic Neurogenesis
Target
-